Trility Life Sciences is developing targeted enteral formulas to address Disease Related Malnutrition that supports patient’s recovery and to optimize their health span.
Patients and health care providers expect better solutions for addressing nutrition deficiencies that provoke complications in oncology and infectious disease.
Trility’s evidence-based polyphenol rich, plant based enteral formula, ACEND, provides patients with an unprecedented combination of essential phytochemicals that are based on decades of peer reviewed studies that have characterized the benefits of phytochemicals in human health.
Trility utilizes the best possible ingredients to optimize the clinical value of our enteral products.
Trility is committed to taking bold steps in research, to exploring new targets that drive health outcomes in innovative ways, to evolving as a leader in the life science industry, connecting with patient advocacy groups and demonstrating an unwavering commitment to fair pricing and social responsibility.
Trility – committed to the next generation of clinical human nutrition.